2020年8月1日
Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis.
Internal medicine (Tokyo, Japan)
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 59
- 号
- 15
- 開始ページ
- 1849
- 終了ページ
- 1853
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.2169/internalmedicine.4593-20
A 66-year-old Japanese man was admitted to our hospital with grade 2 hepatic encephalopathy (HE). Abdominal computed tomography and laboratory examinations revealed decompensated liver cirrhosis. Intravenous administration of branched-chain amino acids immediately ameliorated the HE, and lactulose was initiated. However, a breath test revealed small intestinal bacterial overgrowth (SIBO); therefore, rifaximin was additionally initiated. The breath test was repeated after discharge, when no evidence of SIBO or overt HE was identified. This case suggested that a breath test is effective for the identification of SIBO and that the administration of a poorly absorbed antibiotic should be considered in SIBO-positive HE patients taking lactulose.
- リンク情報
- ID情報
-
- DOI : 10.2169/internalmedicine.4593-20
- PubMed ID : 32321898
- PubMed Central 記事ID : PMC7474984